Karyopharm Prices Public Offering Of 2.65 Mln Shares Of Common Stock

(RTTNews) - Karyopharm Therapeutics (KPTI) announced the pricing of its underwritten public offering of 2.65 million shares of its common stock at a price of $42.50 per share before underwriting discounts.

The company is selling 2.45 million shares of its common stock in this offering, and certain existing stockholders are selling 200,000 shares of common stock. The offering is expected to close on or about July 2.

Karyopharm will not receive any proceeds from the sale of shares by the selling stockholders. In addition, Karyopharm has granted the underwriters a 30-day option to purchase up to an additional 397,087 shares of its common stock, at the public offering price, less the underwriting discount.